Strategies to enhance the therapeutic efficacy of autologous hematopoietic stem cell transplantation by posttransplantation adoptive transfer of T cells with engineered graft-versus-tumor activity.
Jensen
Michael
M
Cancer Immunotherapeutics Program, City of Hope National Medical Center/Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA 91010, USA. mjensen@coh.org
D020350:Graft vs Tumor Effect; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D037182:T-Cell Antigen Receptor Specificity; D013601:T-Lymphocytes / Q000276:immunology / Q000637:transplantation; D013810:Therapeutic Equivalency; D014182:Transplantation, Autologous